(Total Views: 892)
Posted On: 12/04/2021 11:32:23 PM
Post# of 154090
Right to Try might be back on the table- per Kevin on the FB CytoDyn Investor Group page (looks pretty legit to me).
Kevin posted (today) a response from Dr. Kelly when asked how to get access to leronlimab:
"In order to receive leronlimab it must be requested by the treating physician as a "right to try" application. They can reach out to me directly.
Best, skelly@cytodyn.com Scott A. Kelly, M.D."
Kevin relays that he sent a second question to Dr. Kelly for clarification of indications. Dr. Kelly replied that they support Right To Try for Cancer and Critical COVID-19.
According to another poster (Jeff), he requested and got the same information from CytoDyn and relayed that he noticed that 'nothing has been said publicly by CytoDyn, and none of the Expanded Access Program links have been added back to the website.'
Kevin posted (today) a response from Dr. Kelly when asked how to get access to leronlimab:
"In order to receive leronlimab it must be requested by the treating physician as a "right to try" application. They can reach out to me directly.
Best, skelly@cytodyn.com Scott A. Kelly, M.D."
Kevin relays that he sent a second question to Dr. Kelly for clarification of indications. Dr. Kelly replied that they support Right To Try for Cancer and Critical COVID-19.
According to another poster (Jeff), he requested and got the same information from CytoDyn and relayed that he noticed that 'nothing has been said publicly by CytoDyn, and none of the Expanded Access Program links have been added back to the website.'
(10)
(0)
